Sio Gene Therapies, Inc. (SIOX) Social Stream
SIO GENE THERAPIES INC (SIOX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SIOX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 5 | $12.5 | $6 | $8.583 | $0.405 | 2019.26% |
| 2022-02-01 | 5 | $12.5 | $1 | $6.416 | $0.405 | 1484.2% |
| 2022-02-11 | 5 | $12.5 | $1 | $6.3 | $0.405 | 1455.56% |
| 2022-02-14 | 5 | $12.5 | $1 | $6.2 | $0.405 | 1430.86% |
| 2022-04-28 | 4 | $12.5 | $0.8 | $7.1 | $0.405 | 1653.09% |
| 2022-06-15 | 3 | $12.5 | $0.6 | $6.55 | $0.405 | 1517.28% |
| NA | 1 | $NA | $NA | $NA | $0.405 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
Over the past 49 weeks, SIOX's average price target has gone down $1.87.
Over the past 48 days, SIOX's average upside potential has been 1,984.97%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-28 | 4 | 12.5 | 0.8 | 7.10 | 0.31 | 2190.32% |
| 2022-04-28 | 4 | 12.5 | 0.8 | 6.65 | 0.31 | 2045.16% |
| 2022-06-15 | 3 | 12.5 | 0.6 | 6.55 | 0.36 | 1719.44% |
SIOX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 1 | 0 | 1 | 1 | 1 | 3 |
The Trend in the Broker Recommendations
SIOX's average broker recommendation rating worsened by 1.8 over the prior 35 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how SIO GENE THERAPIES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 683.77% of that group.
- To contextualize these metrics, consider that out of all US stocks, SIO GENE THERAPIES INC's variance in analysts' estimates is lower than -563.9% of them.
- In the context of stocks in the mid market cap category, SIO GENE THERAPIES INC's average analyst price target is greater than 39.36% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, SIO GENE THERAPIES INC's number of analysts covering the stock is higher than 130.3% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SIO GENE THERAPIES INC are ASND, QURE, and KDNY.
View All Top Stocks by Price Target
Make investment decisions regarding SIOX using the data that counts. Try POWR Ratings for free.